Results 281 to 290 of about 258,738 (344)

Loss of NR2F6 Protects from Salmonella Typhimurium Infection

Advanced Science, EarlyView.
Loss of nuclear receptor NR2F6 reduces tissue‐resident macrophage populations. Nr2f6‐deficient mice are protected from weight loss and bacterial load during infection with Salmonella Typhimurium. Pro‐inflammatory cytokines and iron levels are altered in infected Nr2f6‐deficient mice.
Johannes Woelk, Christa Pfeifhofer‐Obermair, Julia Benz, Natascha Brigo, Milena Bamberger, Alexeja Kleiter, Martin Hermann, Guenter Weiss, Natascha Hermann‐Kleiter   +8 more
wiley   +1 more source

Improvement of medication adherence in osteoporosis through telemedicine combined with email: a patient-reported experience and outcome measure-based prospective study. [PDF]

BMJ Health Care Inform
Mazziotti G, Pongiglione B, Carrone F, Meregaglia M, Angelucci A, Costantino ML, Aliverti A, Lania AGA, Compagni A.   +8 more
europepmc   +1 more source

The latest research on advanced gynecological oncology: A therapeutic perspective

Cancer Pathogenesis and Therapy
Bohao Zheng, Jinlu Ma, Shengtao Zhou
doaj  

Radiotherapy combined with anlotinib for refractory leiomyosarcoma: a case report and literature review. [PDF]

Front Oncol
Li Z, Yu X, Xu M.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Combined modality therapy

Current Opinion in Oncology, 1991
Encouraging results continue to emerge with the use of chemoradiotherapy. This review of the current literature demonstrates some of the advances that have been achieved in a variety of common malignancies with strategies based on well-defined rationales.
Timothy J. Kinsella, Cornelius J. McGinn
openaire   +3 more sources

Combined modality therapy of esthesioneuroblastoma

Otolaryngology–Head and Neck Surgery, 2007
ObjectiveEsthesioneuroblastoma (ENB) is a rare tumor of the olfactory epithelium. The objective of this study was to evaluate treatment modalities including surgery, IMRT, and chemotherapy and patient outcomes.Patients and MethodsA retrospective analysis was performed on a total of 21 patients.
Susan Muller, Sunjay R Nunley, Peter A.S. Johnstone, J. Nicolas McLean, Charles E. Moore, Carmen M. Klass   +5 more
openaire   +3 more sources

Combined Modality Therapy for Rectal Cancer

The Cancer Journal, 2010
The standard adjuvant treatment for cT3 and/or N+ rectal cancer is preoperative chemoradiation. However, there are many controversies regarding this approach. These include the role of short course radiation, whether postoperative adjuvant chemotherapy necessary for all patients and whether the type of surgery after chemoradiation should be based on ...
Minsky, Bd, Roedel, C, Valentini, Vincenzo   +2 more
openaire   +4 more sources

Combined Modality Therapy of Gastric Cancer

Surgical Oncology Clinics of North America, 1997
Most patients with adenocarcinoma of the stomach continue to present with advanced stages of disease. Although cure is not possible without complete resection, most patients will go on to recur and die of their disease. Despite the efforts of the last 3 to 4 decades, little progress has been made in improving disease specific survival.
David P. Kelsen, Martin S. Karpeh
openaire   +3 more sources